Xoma Depositary Shares Rep Series B 8.375% Cumulative Preferred StockXOMAO
XOMAO
About: XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. When XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes.
Employees: 13
–
Funds holding %
of 6,809 funds
–
Analysts bullish %
Fund manager confidence
Research analyst outlook
We haven’t received any recent analyst ratings for XOMAO.
Financial journalist opinion
We haven’t received any recent news articles for XOMAO.
Charts implemented using Lightweight Charts™